CSL Brazil Biostate Human Coagulation Factor VIII (Post Clinical Trial Supply) 500 IU / von Willebrand Factor 1200 IU powder for injection vial with diluent ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

csl brazil biostate human coagulation factor viii (post clinical trial supply) 500 iu / von willebrand factor 1200 iu powder for injection vial with diluent

csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1200 iu - injection, solution - excipient ingredients: water for injections - biostate is indicated for: - the treatment and prophylaxis of bleeding episodes including surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. - the treatment and prophylaxis of bleeding associated with fviii deficiency due to haemophilia a.

CSL Malaysia Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1200IU complex, Powder for injection (50IU/mL FVIII) ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

csl malaysia aleviate human coagulation factor viii 500iu/von willebrand factor 1200iu complex, powder for injection (50iu/ml fviii)

csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1200 iu - injection, diluent for - excipient ingredients: water for injections - aleviate is indicated for: ? the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. ? the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.

CSL Malaysia Aleviate Human Coagulation Factor VIII 250IU/von Willebrand factor 600IU complex, Powder for injection (50IU/mL FVIII) ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

csl malaysia aleviate human coagulation factor viii 250iu/von willebrand factor 600iu complex, powder for injection (50iu/ml fviii)

csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 600 iu - injection, diluent for - excipient ingredients: water for injections - aleviate is indicated for: ? the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. ? the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.

CSL Hong Kong Biostate Human Coagulation Factor VIII 250IU/von Willebrand factor 500IU complex, Powder for injection (50IU/mL FVIII) ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

csl hong kong biostate human coagulation factor viii 250iu/von willebrand factor 500iu complex, powder for injection (50iu/ml fviii)

csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 500 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. - the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.

Brancico XL 300mg tablets यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

brancico xl 300mg tablets

zentiva pharma uk ltd - quetiapine fumarate - modified-release tablet - 300mg

Brancico XL 200mg tablets यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

brancico xl 200mg tablets

zentiva pharma uk ltd - quetiapine fumarate - modified-release tablet - 200mg

Brancico XL 150mg tablets यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

brancico xl 150mg tablets

zentiva pharma uk ltd - quetiapine fumarate - modified-release tablet - 150mg

Brancico XL 50mg tablets यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

brancico xl 50mg tablets

zentiva pharma uk ltd - quetiapine fumarate - modified-release tablet - 50mg

Brancico XL 400mg tablets यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

brancico xl 400mg tablets

zentiva pharma uk ltd - quetiapine fumarate - modified-release tablet - 400mg

Membrane, internal, tympanic ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

membrane, internal, tympanic

medtronic australasia pty ltd - 34410 - membrane, internal, tympanic - the device is intended for use as a protective cover of a clean, dry perforation in a dry ear.